Objective In the presented study, we aimed to systematically analyze plasma proteomes in cord blood samples from preterm infants stratified by their gestational age to identify proteins and related malfunctioning pathways at birth, possibly contributing to the complications observed among preterm infants. Study design Preterm newborns were enrolled of three subgroups with different gestation age: newborns born ≤26 (group 1), between 27 and 28 (group 2) and between 29 and 30 (group 3) weeks of gestation, respectively, and compared to the control group of healthy, full-term newborns in respect to their plasma proteome composition. Result Preterm delivery is associated with multiple protein abundance changes in plasma related to a plethora of processes, including inflammation and immunomodulation, coagulation, and complement activation as some key features. Conclusion Plasma proteome analysis revealed numerous gestation-age-dependent protein abundance differences between term and preterm infants, which highlight key dysregulated pathways and potential new protein treatment targets.
Introduction
There is a growing body of evidence that abnormal intrauterine conditions and early life events result in longlasting or permanent structural and functional systemic alterations [1] . These observations paved the way to the proposal of the "fetal origin of disease hypothesis" or "Barker's hypothesis", which links the pregnancy complications or fetus development deficits with the increased infant's risk for several cardiovascular and metabolic diseases in the adult life, including type 2 diabetes mellitus, hypertension, or coronary heart disease [2] [3] [4] . However, the knowledge of the exact mechanisms of such "fetal programming" of the disease is still incomplete and speculative.
Progress achieved in the development of intensive care in the past few decades has resulted in increased survival of the smallest infants. However, the improved survival of very low birth weight (VLBW) infants has led to an increased rate of complications, which is the underlying reason for a higher rate of infant mortality and morbidity. Complications of prematurity are considered as complex diseases. Their pathogenesis depends on the interaction of a susceptible host with a multitude of environmental risk factors mutually percolating in a systemic manner, which can be reflected in an altered plasma protein pattern. Research tool which can simultaneously evaluate many different environmental and genetic factors is expected to make progress in our understanding of pathogenesis of complications of prematurity. Proteomics seem to be very promising in the context of assessment of genetic factors due to fully quantitative mass spectrometry, which allows for global analysis of proteins, including their identification and relative ratio determination. Thus, in the present study, we aimed to systematically analyze plasma proteome changes in cord blood samples from preterm infants stratified by their gestational age to search for protein indicators of malfunctioning signaling pathways.
Materials and methods

Patients
A prospective study was conducted between 1 September 2013, and 30 November, 2015. Two cohorts of children were collected: preterm group and control group. Within the preterm cohort three subgroups was defined: subgroup 1-newborns born ≤26 weeks of gestation, 2-newborns born between 27 and 28 weeks of gestation, and 3-newborns born between 29 and 30 weeks of gestation. The control group included healthy, full-term newborns. All preterm infants were born in the tertiary perinatal carel center (Warsaw Medical University Hospital) and all control children were born in the level I city hospital (Cracow). N = 19 patients were enrolled to each preterm subgroup well as the full-term control. The power analysis (http://www. dssresearch.com/toolkit/default.asp) indicated that with n = 19 patients in each preterm group, the estimated power of the study to validate the measured fold change at the level of 1.15 was 0.98 (p = 0.05). The mean fold change protein abundance coefficient of variation (CV) was 15.9%, 15.8%, and 15.2% for preterm group 1, 2, and 3, respectively (15.6% overall).
Inclusion criteria included the gestational age ≤30 weeks and age at the admission to the hospital ≤48 h. Multiple congenital malformation was the exclusion criterion. Detailed perinatal history (birth weight, gestational age) and maternal history were recorded after birth. The study was approved by the Ethics Committee of the Jagiellonian University, Faculty of Medicine number KBET/48/B/2013 from 4 April 2013. Written informed consent was obtained before birth from the parents of all participants involved in the study. During delivery 1 ml of umbilical cord blood has been collected, immediately centrifuged (2000 g, 10 min, 4°C
) to separate plasma, deeply frozen (−70°C) and transferred to the laboratory of the Jagiellonian University in Cracow.
Plasma proteins quantitation
The detailed protocol describing low abundant plasma proteins enrichment, labeling and subsequent liquid chromatography-mass spectrometry quantitation is available in Supplementary Material. Briefly, ProteoMiner beads (Combinatorial Peptide Ligand Library beads, CPLL, Bio-Rad, Hercules, CA) were used for the enrichment procedure, optimized with the reference to previously published protocols [5, 6] . The quantitative analysis was performed by isobaric tag for relative and absolute quantitation (iTRAQ) method (Sciex, Framingham, MA). Samples were enriched, trypsin-digested, randomly assigned to iTRAQ reagents, labeled and finally combined to corresponding 8plex assemblies. Next, labeled peptides were fractionated by Strong Cation Exhange (SCX) chromatography, after which flow-through fraction and 11 consecutive injections of the elution buffer (5-500 mM ammonium acetate) were collected. Thus, the labeled peptides from each 8plex assembly were distributed across 12 SCX fractions. Each fraction was then separated by reversed-phased liquid chromatography and applied online to a Velos Pro (Thermo Scientific, Waltham, MA) mass spectrometer through nano-electrospray ion source. Spectra were collected in full scan mode (400-1500 Da), followed by five pairs of Collisional-Induced Dissociation (CID) and Higher Energy Collisional Dissociation (HCD) MS/MS scans of the five most intense precursor ions from the survey full scan and subsequently merged to hybrid HCD-CID spectra by EasierMGF software [7] . These were analyzed by the X!Tandem (The GPM Organization) [8] and Comet [9] search engines, statistically validated with PeptideProphet and integrated with iProphet [10] under TransProteomic Pipeline (TPP) suite of software (Institute for Systems Biology, Seattle, WA, USA) [11] . Peptide false discovery rate (FDR) was estimated by Mayu [12] (TPP) and peptide identifications with FDR below 1% were considered as correct matches. DanteR software [13] was used for protein quantitation and the statistical analysis of iTRAQ-labeled peptides. ANOVA was performed at the peptide level using a linear model with the Benjamini and Hochberg FDR correction used to adjust p-values. Complete list of all validated unique peptides (FRD < 1%) and their corresponding quantitative signals used for quantitation are collected in Supplemental Table S2 (online) Protein fold change was reported as median value of corresponding unique peptides. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE [14] partner repository with the dataset identifier PXD009806.
Results
Fifty-seven preterm (19 in each subgroup) and 19 full-term newborns were included in the study. The mean birth weight of preterm cohort was 1002 g (SD: 250), and the mean gestational age was 27 weeks (SD: 1.0). The clinical characteristics of the preterm subgroups are presented in Table 1 . The control group included 10 girls and 9 boys, all with birth weight between 2500 and 4000 grams.
In total, 1756 unique iTRAQ-labeled peptides were successfully sequenced and annotated with the FDR below 1% in ProteoMiner-depleted plasma samples in proteomic analysis. A total of 656 of them were constantly present in all analyzed samples across all LC-MS/MS runs, allowing for identification of a total number of 245 proteins in plasma samples. The abundance level of 58, 61, and 65 of them for preterm group 1, 2, and 3, respectively, were significantly different as compared to term-delivered controls ( Table 2) .
The quantitative comparisons between the groups of preterm born patients revealed the significant changes in the abundance of 46 and 43 proteins in gestation groups 2 and 3, respectively, as compared to the newborns born before 26 weeks of gestation (group 1) (Supplemental Table S1 ). Plasma samples from groups 2 and 3 exhibited the highest degree of similarity in all of the comparisons, with the total number of 23 statistically significant proteins with altered plasma concentration (Supplemental Table S1 ).
Discussion
The main finding of our study is that preterm delivery is associated with the multiple protein abundance changes in plasma which can be successfully revealed by iTRAQ quantitation. Affected processes included inflammation, immunomodulation (i.e. orosomucoid, leucine-rich alpha-2-glycoprotein, and L-selectin), coagulation and complement activation, as well as plasma protease inhibitors and apolipoproteins, encompassing both: proteins previously reported and several novel markers of prematurity. Additionally, our measurements within the plasma proteome indicate that the level of prematurity determines profound impact on the plasma protein quantitative changes.
Pro-inflammatory cytokines and other mediators of inflammation and immunity have been recognized as important and causal determinants in the preterm infants, leading to adverse neonatal outcomes through multiple mechanisms, typically involving the induction of reactive oxygen species, which drives the endothelial cell damage, hemostatic abnormalities and augments inflammatory reactions [15] [16] [17] [18] . Interestingly, our data provide the insights into novel markers of disrupted balance in inflammation status and immunomodulation found in the preterm plasma. First, we identified the marked and unequal downregulation of orosomucoid 1 and 2 isoforms (Table 2) , extending the previously reported findings for global orosomucoid level in VLBW infants [19] . More, comparisons between preterm groups additionally point to the repression of orosomucoid isoforms in groups 2 and 3 as compared to the group 1 neonates (Supplemental Table S1 ). Orosomucoid (ORM) has been implicated in the numerous pathways as an antiinflammatory and immunomodulatory protein, being a systemic answer to a inflammatory stimulus, which rises several fold in serum during an acute-phase response [20] . Anti-inflammatory and immunomodulatory properties of ORM are mainly attributed to its ability to inhibit the superoxide production by neutrophils, to promote interleukin-1 receptor antagonist (IL1RA) secretion and to modulate the cytokines production from monocytes [20, 21] . Moreover, ORM has been described as an inducer of quiescent macrophages polarization to M2b phenotype, which is believed to be beneficial in controlling opportunistic infections [22] . In line with these observations, we found increased levels of leucine-rich alpha-2-glycoprotein (LRG1) in preterm patients, regardless the gestation age (Table 2 ). LRG1 production in the liver increases in response to mediators of the acute-phase, while serum LRG1 levels are elevated during bacterial infections due to its secretion from activated neutrophils [23, 24] . More, LRG1 induction has been attributed to several neoplastic and inflammatory disorders, suggesting its biomarker potential [25, 26] . Of note, the induction of LRG1 plasma level was negatively correlated with the gestation age (Table 2) . Additionally, anti-inflammatory zinc-alpha-2-glycoprotein (ZAG) and afamin were downregulated in all preterm subgroups, regardless the gestation age ( Table 2) . 
Proteases and protease inhibitors
The former is an adipokine produced by adipose tissue, positively correlated with adiponectin expression [27] , while the latter is a vitamin E-binding protein, which can transport alpha-and gamma-tocopherol in body fluids under physiological and pathological conditions, when the lipoprotein system is not sufficient for vitamin E transport [28] . Interestingly, Lu et al. [29] reported the downregulation of afamin as one of the potential plasma markers of diabetic retinopathy and attributed it to the decreased ability in removing reactive oxygen species as a consequence of the impaired vitamin E transport in the circulation. Since retinopathy of prematurity is one of the most frequent preterm clinical complication, we are tempted to speculate that decreased level of afamin may represent a hallmark of detrimental oxidative stress in prematurely born patients included in our study. Our proteomic analysis revealed also the decreased circulating L-selectin level in preterm neonates in all three gestation age groups (Table 2) . L-selectin is a cell surface adhesion molecule, but it can also be released as a soluble functional isoform. As such, it reduces the leukocyte adhesion to the endothelium, mitigating infiltration of immune cell during inflammation [30] . Interestingly, Experimental groups symbols describe newborns born before 26 weeks of gestation (G1), newborns born between 27 and 28 weeks of gestation (G2) and newborns born between 29 and 30 weeks of gestation (G3). Quantitative data, representing protein abundance differences between preterm neonates and term controls (G1/G2/G3 to control ratio, respectively) are depicted as median fold change. Missing values indicate the lack of statistical significance of protein abundance change in particular comparison. All presented protein abundance differences are statistically significant (adjusted p < 0.05). Proteins have been grouped according to the biological signaling pathway they are engaged with.
Koehne et al. [31] have demonstrated that in preterm infants with respiratory distress, neonates who responded poorly to surfactant had low L-selectin plasma level as compared to good responders or controls. The authors conclude that low plasma L-selectin at 24 h of age predicts prolonged requirement for supplemental oxygen. Interestingly, we determined the induction in alpha-1-antichymotrypsin (ACT) in extremely preterm neonates, decreasing with gestation age (Table 2) . ACT changes correlated with the plasma angiotensinogen levels in neonates, which decreased progressively with the duration of the pregnancy. ACT can inhibit neutrophil cathepsin G and mast cell chymase, both of which can convert angiotensin-1 to the active angiotensin-2 [32] . One can conclude that the induction of ACT is evoked to countermeasure possible detrimental potentiation of angiotensin-2 due to the facilitated substrate availability. Clearly, the biological relevance of this intriguing finding requires further investigation. Noteworthy, our comprehensive quantitative assessment of plasma protein abundances evidences the immune consequences of the preterm birth, since a panel of IgG components are collectively downregulated in all groups as compared to the term controls (Table 2) . Antigen-specific IgG transfer across the placenta from the maternal circulation increases with fetal age; however, large amounts IgGs translocate to fetus circulation after 32 weeks of gestation [33] . Thus, as evidenced in our dataset, preterm infants have low levels of circulating maternal IgG, resulting in a lack of opsonization, which leads to deficiencies in phagocytosis [34] .
Interestingly, our proteomic analysis provided a strong evidence for dysregulation of coagulation and complement activation cascades in preterm infants. In preterm plasma samples, we report a downregulation of alpha-2-antiplasmin, alpha-1-antitrypsin and antithrombin-III levels, accompanied by a marked induction of coagulation factor X and especially factor V (Table 2) , which is a central regulator of hemostasis. Decrease in alpha-2-antiplasmin and antithrombin-III plasma concentrations were additionally related to the gestation age. However, at the same time, we evidenced the decrease in several other coagulationengaged proteins, including prothrombin (over twofold in all gestation age groups), vitronectin and all fibrinogen subunits in preterm neonates. The pediatric hemostatic system changes and maturation from fetal to adult form (developmental hemostasis) in an evolving process confirmed by several studies [35] [36] [37] [38] [39] . They demonstrate that in neonates the plasma levels of most coagulation factors are around twofold decreased as compared with the adults, while the preterm newborns having lower levels than fullterm ones. Decreased coagulation potential and its regulatory properties alongside the increased fibrinolytic activity in neonates is partially counterbalanced with the enhanced primary hemostasis components, including platelets count and von Willebrand factor level [40] . The majority of coagulation and complement protein abundance changes identified in our study are in line with the previously reported values of pro-and anti-coagulants [40] , which again validates our dataset. Intriguingly, our analysis revealed the induction of alpha-2-macroglobulin (a2-M) and complement C3 (Table 2 ). Both proteins evolved from a common ancestor gene and, regardless different physiological functions, they are activated (an exposure of internal thioester, which, upon cleavage, becomes covalently associated to the target protease [41, 42] ) and metabolized in the same fashion (low density lipoprotein-receptor-related protein/alpha-2-macroglobulin receptor-mediated clearance) [43] . Alpha-2-macroglobulin is a member of a group of plasma glycoproteins functioning as a "molecular traps" for proteinases [41] . After activation by limited proteolysis, they bind activated proteinases and sequestrate them from its protein substrates, channeling them for rapid clearance and degradation [41] . Importantly, a2-M is known to participate in the regulation of coagulation in a complex manner, since at physiological amounts of antithrombin, it exhibits pro-coagulant activity related to activated protein C (APC) binding [44] . On the contrary, a2-M can exhibit anticoagulant properties, since it can bind free α-thrombin in the antithrombin-deficient plasma [41] . As suggested by Mitchell et al., this mechanism of α-thrombin-a2-M complex formation may explain the a2-M-mediated protection from thromboembolic events in antithrombin-deficient children [45] . Of note, a2-M levels in newborns are elevated over adult values [37, 38] . Thus, regarding detected antithrombin-III downregulation in all groups of preterm patients enrolled in presented study, one can hypothesize that the gestation age-dependent upregulation of a2-M may represent a possible protective mechanism identified in our proteomic study, counteracting disturbances in the regulation of coagulation network. Of note, a2-M plasma levels were lower in extremely preterm infants than those in more mature preterms, suggesting the gestation age-dependent regulation of a2-M plasma secretion. Thus, whether this phenomenon possesses physiological significance remains an attractive hypothesis to be tested in targeted prospective study.
Finally, we noted also the disturbances in the hemoglobin/heme turnover network in preterm neonates. Several subunits of hemoglobin (profoundly the hemoglobin gamma chain-a constituent of fetal hemoglobin), that were all jointly upregulated in correlation to the duration of the pregnancy (Table 2) . More, these changes were indirectly validated by the observed gestation age-dependent decreased concentration of hemopexin (Table 2) , a hemescavenging protein secreted to prevent the pro-oxidant and pro-inflammatory effects of heme [46, 47] . The elevated hemoglobin level was accompanied by a decrease in the plasma abundance of key hemoglobin/heme-binding proteins: haptoglobin and alpha-fetoprotein, while the serotransferrin level was consistently decreased in all groups of patients (Table 2) . More, the induction of hemoglobin subunits and the repression of hemopexin were gestationage dependent. Free plasma hemoglobin assessed in our quantitative analysis likely originate from erythrocyte hemolysis, which is recognized as an important cause of hyperbilirubinemia in premature and term neonates [48] . Decreased erythrocyte survival and its increased volume augment hemolysis, which introduces the imbalance between bilirubin production and elimination [49] . The ability to handle unconjugated bilirubin is relatively immature in preterm infant as compared with term neonate, which predispose to a high risk for marked neonatal jaundice [49] . Importantly, neonatal hyperbilirubinemia in late preterm newborns is more prevalent, more pronounced, and more prolonged than in their term counterparts [50] . Our results are in line with these observations and broaden the insights into the possible mechanistic cause of the heme/hemoglobin turnover imbalances in the preterm neonates.
In summary, the systematic quantitative analysis of plasma proteome changes in cord blood samples from preterm infants revealed that there are significant protein expression differences between preterm and term infants, as well as among preterm groups stratified by their gestation age. Our results point to the global disturbances in the inflammatory and immunomodulation mechanisms (ORM, LRG1, ZAG, and afamin), as well as in coagulation (fibrinogens and antithrombin-III) and complement activation cascades (C1s, C1r, and C3) as key features, with gestation age-dependent a2-M induction representing an interesting adaptive response and possible protective mechanism identified in our proteomic study, evolved to counteract coagulation disturbances. Interestingly, our data provide the novel insights into the time-dependent malfunction of heme/hemoglobin turnover network in preterm neonates.
